Author: K-STOCK Editor
[Disclosure] Celltrion (068270) – CT-P13 SC (Zymfentra) Korea Phase 3 Clinical Trial Plan Application (Rheumatoid Arthritis Patients) / 2026-07-24
[Disclosure] Wonik IPS (240810) – Setting of Record Date or Period for Suspension of Entry of Change in Shareholders’ Register / 2026-07-24